Get the Stockscreener App
6.30
0.32%
-0.02
After Hours:
6.49
0.19
+3.02%
Bolt Biotherapeutics Inc stock is traded at $6.30, with a volume of 16,323.
It is down -0.32% in the last 24 hours and up +12.30% over the past month.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$6.32
Open:
$6.37
24h Volume:
16,323
Relative Volume:
0.65
Market Cap:
$12.08M
Revenue:
$7.88M
Net Income/Loss:
$-69.20M
P/E Ratio:
-3.4426
EPS:
-1.83
Net Cash Flow:
$-69.73M
1W Performance:
+9.85%
1M Performance:
+12.30%
6M Performance:
-36.36%
1Y Performance:
-58.00%
1-Day Range:
$6.13
$6.4899
1-Week Range:
$5.61
$6.8699
52-Week Range:
$5.20
$15.60
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Name
Bolt Biotherapeutics Inc
Sector
Industry
Phone
650-665-9295
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
6.30 | 12.12M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-21 | Initiated | Guggenheim | Buy |
| Mar-02-21 | Initiated | Morgan Stanley | Overweight |
| Mar-02-21 | Initiated | SVB Leerink | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
Bolt Biotherapeutics Inc Stock (BOLT) Latest News
Using economic indicators to assess Bolt Biotherapeutics Inc. potentialInvestment Position Summary with Timeframe Forecast - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stock AI-Powered Stock Trend Movement Analysis - Newser
Will earnings trigger a reversal in Bolt Biotherapeutics Inc. Weekly Stock Market Strategy Summary - Newser
Should I hold or sell Bolt Biotherapeutics Inc. stock in 2025Achieve superior capital gains with smart trades - jammulinksnews.com
What institutional investors are buying Bolt Biotherapeutics Inc. stockRapid return acceleration - jammulinksnews.com
How strong is Bolt Biotherapeutics Inc. company’s balance sheetFree Investment Community - jammulinksnews.com
Is Bolt Biotherapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Access to Community - Newser
How Bolt Biotherapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
How many analysts rate Bolt Biotherapeutics Inc. as a “Buy”Build a portfolio that delivers consistent profits - jammulinksnews.com
What analysts say about Bolt Biotherapeutics Inc. stockFree Capital Efficiency Planning - PrintWeekIndia
Bolt Biotherapeutics Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Will Bolt Biotherapeutics Inc. stock benefit from interest rate changesConsistently superior profits - jammulinksnews.com
What institutions are buying Bolt Biotherapeutics Inc. stock nowConsistent double returns - jammulinksnews.com
What drives Bolt Biotherapeutics Inc. stock priceMarket-crushing stock picks - PrintWeekIndia
Is Bolt Biotherapeutics Inc. a good long term investmentFree Advanced Stock Screener Access - Autocar Professional
What analysts say about Humana Inc. stockBreakthrough stock performance - jammulinksnews.com
Best Banking Stocks Trending Investment StocksHigh-yield capital appreciation - jammulinksnews.com
What drives ESLA stock priceHigh-yield trading alerts - Autocar Professional
AvePoint Inc. Equity Warrant Stock Analysis and ForecastDynamic investment growth - Autocar Professional
India’s Best Performing Stocks for the Last Decade High Potential Market MoversHigh-impact stock picks - Autocar Professional
Company Incorporated stock pay reliable dividendsHigh Potential Safe Trades - beatles.ru
Is Citius Pharmaceuticals Inc. stock a growth or value playROI Focused Stock Calls - Newser
How Gulfport Energy Corporation stock reacts to Fed policy changesSecure Growth Trading Plan - Newser
Bolt Biotherapeutics Inc Stock (BOLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):